| 151 |
REPLReplimune Group, Inc. |
Life Sciences |
0.35 |
$1.0B |
Unlock rating and forecasts |
| 152 |
MNKDMANNKIND CORP |
Life Sciences |
0.62 |
$977M |
Unlock rating and forecasts |
| 153 |
IMTXImmatics N.V. |
Life Sciences |
0.35 |
$902M |
Unlock rating and forecasts |
| 154 |
MGTXMeiraGTx Holdings plc |
Life Sciences |
0.31 |
$891M |
Neutral |
-0.27% |
-0.53% |
· |
| 155 |
QDELQuidelOrtho Corp |
Life Sciences |
0.06 |
$885M |
Neutral |
-0.42% |
-0.92% |
▲ 1 |
| 156 |
ANROAlto Neuroscience, Inc. |
Life Sciences |
0.22 |
$861M |
Unlock rating and forecasts |
| 157 |
RIGLRIGEL PHARMACEUTICALS INC |
Life Sciences |
0.05 |
$859M |
Neutral |
-0.06% |
-0.08% |
· |
| 158 |
CYRXCryoport, Inc. |
Life Sciences |
0.29 |
$853M |
Neutral |
-0.09% |
-0.14% |
· |
| 159 |
ABUSArbutus Biopharma Corp |
Life Sciences |
0.03 |
$835M |
Unlock rating and forecasts |
| 160 |
CGEMCullinan Therapeutics, Inc. |
Life Sciences |
0.40 |
$832M |
Unlock rating and forecasts |
| 161 |
GLUEMonte Rosa Therapeutics, Inc. |
Life Sciences |
0.15 |
$831M |
Unlock rating and forecasts |
| 162 |
AVBPArriVent BioPharma, Inc. |
Life Sciences |
0.19 |
$821M |
Unlock rating and forecasts |
| 163 |
ALMSALUMIS INC. |
Life Sciences |
0.28 |
$792M |
Unlock rating and forecasts |
| 164 |
VSTMVerastem, Inc. |
Life Sciences |
0.31 |
$783M |
Unlock rating and forecasts |
| 165 |
HELPHelus Pharma Inc. |
Life Sciences |
0.18 |
$771M |
Unlock rating and forecasts |
| 166 |
ARDXARDELYX, INC. |
Life Sciences |
0.39 |
$770M |
Neutral |
-0.21% |
-0.39% |
· |
| 167 |
COLLCOLLEGIUM PHARMACEUTICAL, INC |
Life Sciences |
0.63 |
$755M |
Neutral |
-0.41% |
-0.91% |
▲ 1 |
| 168 |
GERNGERON CORP |
Life Sciences |
0.11 |
$752M |
Unlock rating and forecasts |
| 169 |
IVAInventiva S.A. |
Life Sciences |
0.25 |
$709M |
Unlock rating and forecasts |
| 170 |
DNAGinkgo Bioworks Holdings, Inc. |
Life Sciences |
0.30 |
$692M |
Unlock rating and forecasts |
| 171 |
SANASana Biotechnology, Inc. |
Life Sciences |
0.26 |
$680M |
Unlock rating and forecasts |
| 172 |
LXRXLEXICON PHARMACEUTICALS, INC. |
Life Sciences |
0.44 |
$676M |
Unlock rating and forecasts |
| 173 |
FDMT4D Molecular Therapeutics, Inc. |
Life Sciences |
0.21 |
$670M |
Unlock rating and forecasts |
| 174 |
IMMXImmix Biopharma, Inc. |
Life Sciences |
0.31 |
$662M |
Unlock rating and forecasts |
| 175 |
ACHVACHIEVE LIFE SCIENCES, INC. |
Life Sciences |
0.41 |
$657M |
Unlock rating and forecasts |
| 176 |
ANNXAnnexon, Inc. |
Life Sciences |
0.29 |
$646M |
Unlock rating and forecasts |
| 177 |
DSGNDesign Therapeutics, Inc. |
Life Sciences |
0.24 |
$645M |
Unlock rating and forecasts |
| 178 |
GYREGYRE THERAPEUTICS, INC. |
Life Sciences |
0.05 |
$645M |
Unlock rating and forecasts |
| 179 |
AURAAura Biosciences, Inc. |
Life Sciences |
0.42 |
$633M |
Unlock rating and forecasts |
| 180 |
PRMEPrime Medicine, Inc. |
Life Sciences |
0.21 |
$629M |
Unlock rating and forecasts |
| 181 |
CADLCandel Therapeutics, Inc. |
Life Sciences |
0.42 |
$627M |
Unlock rating and forecasts |
| 182 |
WVEWave Life Sciences, Inc. |
Life Sciences |
0.18 |
$617M |
Unlock rating and forecasts |
| 183 |
AVTXAvalo Therapeutics, Inc. |
Life Sciences |
0.26 |
$604M |
Unlock rating and forecasts |
| 184 |
SLDBSolid Biosciences Inc. |
Life Sciences |
0.13 |
$593M |
Unlock rating and forecasts |
| 185 |
IRWDIRONWOOD PHARMACEUTICALS INC |
Life Sciences |
0.22 |
$578M |
Neutral |
-0.10% |
-0.17% |
▲ 1 |
| 186 |
OLMAOlema Pharmaceuticals, Inc. |
Life Sciences |
0.25 |
$576M |
Unlock rating and forecasts |
| 187 |
SGMTSagimet Biosciences Inc. |
Life Sciences |
0.27 |
$569M |
Unlock rating and forecasts |
| 188 |
CRMDCorMedix Inc. |
Life Sciences |
0.18 |
$566M |
Neutral |
-0.34% |
-0.71% |
· |
| 189 |
CLYMClimb Bio, Inc. |
Life Sciences |
0.46 |
$564M |
Unlock rating and forecasts |
| 190 |
PHATPhathom Pharmaceuticals, Inc. |
Life Sciences |
0.16 |
$560M |
Unlock rating and forecasts |
| 191 |
STTKShattuck Labs, Inc. |
Life Sciences |
0.30 |
$544M |
Unlock rating and forecasts |
| 192 |
DBVTDBV Technologies S.A. |
Life Sciences |
0.35 |
$536M |
Neutral |
-0.34% |
-0.70% |
· |
| 193 |
SLNSilence Therapeutics plc |
Life Sciences |
0.13 |
$522M |
Unlock rating and forecasts |
| 194 |
DRUGBRIGHT MINDS BIOSCIENCES INC. |
Life Sciences |
0.22 |
$512M |
Unlock rating and forecasts |
| 195 |
PBYIPUMA BIOTECHNOLOGY, INC. |
Life Sciences |
0.01 |
$507M |
Unlock rating and forecasts |
| 196 |
CBIOGYRE THERAPEUTICS, INC. |
Life Sciences |
0.12 |
$507M |
Unlock rating and forecasts |
| 197 |
CTMXCytomX Therapeutics, Inc. |
Life Sciences |
0.05 |
$497M |
Unlock rating and forecasts |
| 198 |
FTHFaeth Therapeutics, Inc. |
Life Sciences |
0.07 |
$486M |
Neutral |
-0.13% |
-0.23% |
· |
| 199 |
ACRSAclaris Therapeutics, Inc. |
Life Sciences |
0.37 |
$483M |
Unlock rating and forecasts |
| 200 |
EOLSEvolus, Inc. |
Life Sciences |
0.49 |
$469M |
Unlock rating and forecasts |